Global Advocates Welcome the Launch of Merck’s EXPrESSIVE Program
Known as the EXPrESSIVE program, the drug maker Merck has two trials testing a monthly pill for PrEP. Merck is committed to stakeholder engagement, putting global advocates at the forefront of planning for the program. Numerous organizations and advocates commend Merck’s dedication to hearing from the community and shared this statement.
- Topics:
- Centering Communities
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!